X4 Pharmaceuticals Inc (NAS:XFOR)
$ 0.371 -0.022 (-5.6%) Market Cap: 63.27 Mil Enterprise Value: 10.25 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 30/100

Q1 2022 X4 Pharmaceuticals Inc Earnings Call Transcript

May 12, 2022 / 12:30PM GMT
Release Date Price: $1.04 (-0.95%)
Operator

Greetings and welcome to X4 Pharmaceuticals' First Quarter 2022 Financial and Operating Results Conference Call. (Operator Instructions)

As a reminder, this conference call is being recorded.

It is now my pleasure to introduce your host Dr. Glenn Schulman, Head of Investor Relations. Please begin.

Glenn Schulman
X4 Pharmaceuticals - Head of Investor Relations

Thank you, operator. Good morning everyone. Presenting on today's call will be X4's Chief Executive Officer, Dr. Paula Ragan and the company's Chief Financial Officer, Adam Mostafa. Following prepared remarks by each, we will open the call to your questions, during which we'll also be joined by our Chief Scientific Officer, Art Taveras; Chief Medical Officer, Diego Cadavid; and Chief Operating Officer, Mary DiBiase.

As a reminder, on today's call X4 will be making forward-looking statements regarding regulatory and product development plans as well as research activities. These statements are subject to risks and uncertainties that may cause actual results to differ from those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot